Alteraciones de laboratorio y autoanticuerpos

Rider, 1995, Laboratory evaluation of the inflammatory myopathies, Clin Diagn Lab Immunol, 2, 1, 10.1128/CDLI.2.1.1-9.1995 Askari, 1976, Steroid myopathy in connective tissue disease, Am J Med, 61, 485, 10.1016/0002-9343(76)90327-2 Bessman, 1985, The creatine-creatine phosphate energy shuttle, Annu Rev Biochem, 54, 831, 10.1146/annurev.bi.54.070185.004151 Kagen, 1987, Creatine kinase activity inhibitor in sera from patients with muscle disease, Arthritis Rheum, 30, 213, 10.1002/art.1780300212 Josefson, 1996, A functional index in myositis, J Rheumatol, 23, 1380 Vencovsky, 2000, Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis, Scand J Rheumatol, 29, 95, 10.1080/030097400750001897 Hochberg, 1986, Adult onset polymyositis/dermatomyositis: An analysis of clinical and laboratory features and survival in 76 patients with a review of the literature, Semin Arthritis Rheum, 15, 168, 10.1016/0049-0172(86)90014-4 Mandell, 1991, Aldolase in the diagnosis of myositis, Am J Med, 90, 662, 10.1016/S0002-9343(05)80032-4 Miller, 2001, Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies, Rheumatology, 40, 1262, 10.1093/rheumatology/40.11.1262 Munsat, 1973, Serum enzyme alterations in neuromuscular disorders, JAMA, 226, 1536, 10.1001/jama.1973.03230130024009 Helfgott, 1993, Misinterpretation of serum transaminase elevation in “occult” myositis, Am J Med, 95, 447, 10.1016/0002-9343(93)90319-K Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups, Medicine (Baltimore), 70, 360, 10.1097/00005792-199111000-00002 Reichlin, 1984, Multiplicity of antibodies in myositis sera, Arthritis Rheum, 27, 1150, 10.1002/art.1780271011 Marguerie, 1990, Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes, Q J Med, 77, 1019, 10.1093/qjmed/77.1.1019 Hirakata, 1999, Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease, J Immunol, 162, 2315, 10.4049/jimmunol.162.4.2315 Targoff, 1990, Antibody to signal recognition particle in polymyositis, Arthritis Rheum, 33, 1361, 10.1002/art.1780330908 Nilasena, 1995, Analysis of the Mi-2 autoantigen of dermatomyositis, Arthritis Rheum, 38, 123, 10.1002/art.1780380119 Mierau, 1996, Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain, Arthritis Rheum, 39, 868, 10.1002/art.1780390521 Sato, 2005, Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis, Arthritis Rheum, 52, 1571, 10.1002/art.21023 Targoff, 2006, A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis Rheum, 54, 3682, 10.1002/art.22164 Lundberg, 1992, A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies, Semin Arthritis Rheum, 22, 127, 10.1016/0049-0172(92)90006-Y Hirakata, 2005, Association between autoantibodies to the Ku protein and DPB1*, Arthritis Rheum, 52, 668, 10.1002/art.20766 Marguerie, 1992, The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl, Medicine (Baltimore), 71, 327, 10.1097/00005792-199211000-00001